ATAI Launches Subsidiary Focused On Active Ingredient In Hallucinogenic Brews
Psychedelics and biotech company ATAI Life Sciences announced Wednesday the launch of Viridia Life Sciences.
This wholly-owned subsidiary will be dedicated to the study and production of the DMT molecule (N,N-Dimethyltryptamine).
